Delivery Order SPE2DB22D9244-SPE2DB24FZS66

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $4,522.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of 4566120507 CATHFLO ACTIVASE 2 MG VIALS, a specialized pharmaceutical product, with a period of performance through October 17, 2024. This contract award is part of a larger, single-award Indefinite Delivery Contract (IDC) valued...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $1,071.00 for the supply of 4564878329 CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,900.00, is for the delivery of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract has an ultimate completion date of July 23, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA), specifically the Medical Supply Chain division, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,698.30 firm fixed-price delivery order is for the supply of ACTIVASE 100 MG VIALS, with a period of performance through September 5, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
This federal contract award was granted to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,380.00 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the SPE2DB program, a $499,999,999 indefinite delivery contract that runs through December 31, 2025. The contract is for the supply of 4565256274 - CATHFLO ACTIVASE 2 MG VIALS, a specialized pharmaceutical product. DMS Pharmaceutical Group is a key supplier in...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,415.92, is to provide 4559553989 - CATHFLO ACTIVASE 2 MG VIALS to the DLA. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to...
This federal contract award, valued at $3,256.83, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of ACTIVASE 50 MG VIALS, a pharmaceutical product, with a performance period through August 13, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,380.00 firm fixed-price delivery order contract is for the supply of Cathflo Activase 2 mg vials and has an ultimate completion date of August 29, 2024. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $50,793.20 firm fixed-price delivery order is for the supply of 4565677111 ACTIVASE 100 MG VIALS, with an ultimate completion date of August 29, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,698.30 firm fixed-price delivery order is for the supply of ACTIVASE 100 MG VIALS, a critical pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows the agency to issue delivery orders...
  • SPE2DB22D9244
    Indefinite Delivery Contract
  • SPE2DB22D9244-SPE2DB24FZS66
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,570.00 firm fixed-price delivery order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a period of performance through August 29, 2024.

The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing both routine and critical medications to support the diverse medical requirements of the Department of Defense.

Generated 11/27/24, 9:13 AM